Crane ChemPharma
For more than 75 years, Saunders brand diaphragm valves from Crane ChemPharma & Energy have delivered solutions to demanding process applications in the life sciences industry. As the inventor of the diaphragm valve, Saunders has been central to the evolution of high-purity valve technology and will bring this exceptional level of expertise to INTERPHEX. In addition to its extensive line of valve solutions, including the HC4 and S360, Saunders representatives will highlight the reportedly groundbreaking I-VUE valve sensor.
Designed specifically for aseptic diaphragm valve applications in the life sciences industry, the Saunders I-VUE is claimed to be the first valve sensor with no moving parts, eliminating the various problems inherent in traditional, multi-component sensors and switchboxes.
Compatible with Point-to-Point (P2P), AS-i and DeviceNet control systems, the Saunders I-VUE enhances reliability and accuracy through the use of a unique solid-state, continuous sensing technology that provides precise position readings for the entire valve range.
The I-VUE’s automated valve calibration capability simplifies installation and reduces setup time to a mere three minutes or less.
Finally, by applying factory or user-defined device settings to monitor valve cycle count and end-point tolerance limits, the I-VUE prevents false alarms and eliminates unnecessary diaphragm replacement to drastically reduce overall operating and maintenance costs.
Booth 3610, INTERPHEX 2014, 18–20 March 2014, Javits Center in New York City, US.
CRANE ChemPharma & Energy, +1 513 745 6021, mdugan@cranechempharma.com, www.cranechempharma.com.